Page last updated: 2024-09-02
n-(1-methyl-2-phenylethyl)adenosine and B16 Melanoma
n-(1-methyl-2-phenylethyl)adenosine has been researched along with B16 Melanoma in 1 studies
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Amanatullah, DF; Clair, T; Liotta, LA; Schetz, JA; Stracke, ML; Woodhouse, EC | 1 |
Other Studies
1 other study(ies) available for n-(1-methyl-2-phenylethyl)adenosine and B16 Melanoma
| Article | Year |
|---|---|
Adenosine receptor mediates motility in human melanoma cells.
Topics: Adenosine; Adenosine Monophosphate; Animals; Chemotaxis; CHO Cells; Cricetinae; Dose-Response Relationship, Drug; Humans; Melanoma, Experimental; Pertussis Toxin; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; Transfection; Virulence Factors, Bordetella; Xanthines | 1998 |